Abstract Background Testosterone therapy for women is in widespread use, primarily in the form of compounded preparations and off-label use of formulations for men. The benefits and risks of such therapy remain uncertain. This review will identify and evaluate studies that have examined the effects of testosterone therapy for women on a range of outcomes including sexual function, cardiovascular events, metabolic parameters, musculoskeletal health, wellbeing, cancer events, androgenic effects and withdrawal rates. Methods Studies meeting our pre-determined inclusion criteria will be identified through searches in Ovid MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL) and Web of Science. Assessing a range of outco...
Over the past decade, there has been a substantial increase in the number of men who are treated wit...
The expected postmenopausal lifetime of women in the western world is about 30 years. Hormones, such...
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty a...
Background: Testosterone therapy for women is in widespread use, primarily in the form of compounded...
OBJECTIVE: To assess the relative effects of individual testosterone products among hypogonadal men....
The role of Testosterone Therapy (TTh) in the management of male sexual dysfunction remains unclear....
OBJECTIVES: Testosterone supplementation can be considered as a treatment option for surgically post...
Objective: To summarize current evidence regarding testosterone treatment for women with low sexual ...
Testosterone products comprise a multi-billion dollar industry; however, Health Canada and the Unite...
BackgroundIt is not known whether premenopausal women who report low sexual satisfaction and have lo...
Testosterone products are recommended by some prescribers in response to a diagnosis or presumption ...
Background: Testosterone prescriptions have increased dramatically over recent decades with incre...
Background: The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Gl...
With advancing age, there is an increase in the complaints of a lack of a libido in women and erecti...
Introduction: Recent reports have significantly halted the enthusiasm regarding androgen-boosting; s...
Over the past decade, there has been a substantial increase in the number of men who are treated wit...
The expected postmenopausal lifetime of women in the western world is about 30 years. Hormones, such...
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty a...
Background: Testosterone therapy for women is in widespread use, primarily in the form of compounded...
OBJECTIVE: To assess the relative effects of individual testosterone products among hypogonadal men....
The role of Testosterone Therapy (TTh) in the management of male sexual dysfunction remains unclear....
OBJECTIVES: Testosterone supplementation can be considered as a treatment option for surgically post...
Objective: To summarize current evidence regarding testosterone treatment for women with low sexual ...
Testosterone products comprise a multi-billion dollar industry; however, Health Canada and the Unite...
BackgroundIt is not known whether premenopausal women who report low sexual satisfaction and have lo...
Testosterone products are recommended by some prescribers in response to a diagnosis or presumption ...
Background: Testosterone prescriptions have increased dramatically over recent decades with incre...
Background: The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Gl...
With advancing age, there is an increase in the complaints of a lack of a libido in women and erecti...
Introduction: Recent reports have significantly halted the enthusiasm regarding androgen-boosting; s...
Over the past decade, there has been a substantial increase in the number of men who are treated wit...
The expected postmenopausal lifetime of women in the western world is about 30 years. Hormones, such...
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty a...